BIIBNEUTRAL

BIIB Gross Margin Analysis

73.3%

Higher than 67% of Healthcare sector peers

Updated 72h ago·SEC filings & market data

Key Takeaway

Biogen's gross margin of 73.3% means that for every dollar of revenue, the company keeps 73.3 cents after subtracting the direct costs of producing its drugs; a higher gross margin generally indicates stronger pricing power or lower production costs.

Sector Performance

67th percentile

BIIB

73.3%

Sector Median

69.8%

Sector Avg

-24.1%

Prior Period

72.0%(Apr 2026)

↑ Improving
📊

Deep Analysis

Biogen's gross margin of 73.3% means that for every dollar of revenue, the company keeps 73.3 cents after subtracting the direct costs of producing its drugs; a higher gross margin generally indicates stronger pricing power or lower production costs.

This current margin sits above the healthcare sector median of 69.8%, placing Biogen in the 67th percentile among its peers, meaning it outperforms about two-thirds of comparable companies. Trend data is not available — the year-over-year change, quarter-over-quarter change, and the direction over the last eight quarters are all marked as N/A, so no past trajectory can be assessed. The combination of a high gross margin relative to peers with no trend information offers a neutral risk profile: the level suggests competitive efficiency, but the absence of historical movement prevents any conclusion about sustainability or improvement. This metric supports the overall NEUTRAL verdict because the strong current margin provides no clear bullish or bearish signal without trend data to confirm direction.

Frequently Asked Questions

What does the Gross Margin tell investors about BIIB?

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

How is the Gross Margin calculated?

Gross Margin is calculated as: Gross Profit / Revenue.

How does BIIB's Gross Margin compare to its sector?

BIIB's Gross Margin of 73.3% compares to a Healthcare sector median of 69.8%, placing it in the 67th percentile.

Who are BIIB's closest peers by Gross Margin?

The closest Healthcare peers by Gross Margin include: BMY (70.2%), TDOC (67.8%), ZBH (72.4%), TECH (66.9%), VEEV (75.0%).

The Formula

Gross Profit / Revenue

Why It Matters

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

Advertisement

Master BIIB's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full BIIB research report

Free account — no credit card

BIIB

73.3%

Sector Median

69.8%

Sector Avg

-24.1%

How BIIB's Gross Margin compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.